by John Conrad | Sep 25, 2024 | NewsBrief
PCI Pharma Services is set to significantly expand its presence in Rockford, Illinois, as part of a broader $365 million investment across its U.S. and European operations. The contract development and manufacturing organization (CDMO) announced on Tuesday, September...
by John Conrad | Sep 24, 2024 | Member News, NewsBrief
Swedish rare disease specialist Immedica Pharma AB continues to strengthen its position in the U.S. market with two significant announcements this month. Chicago Becomes U.S. Base for Global Rare Disease Company On September 9th, Immedica revealed plans to establish...
by John Conrad | Sep 23, 2024 | Member News
Chicago-based NanoGraf, a leader in advanced silicon anode battery technology, has been awarded a $60 million grant from the U.S. Department of Energy as part of the Bipartisan Infrastructure Law. This substantial funding will support the construction of one of the...
by John Conrad | Sep 19, 2024 | NewsBrief
Syntax Bio has launched with $15 million in funding from notable investors, including Astellas Venture Management LLC and Illumina Ventures. The Chicago-based startup is pioneering a novel approach to cell therapy with its Cellgorithm platform. Syntax Bio’s...
by John Conrad | Sep 19, 2024 | Member News
MAIA Biotechnology (NYSE American: MAIA) has announced encouraging interim survival data for its lead clinical candidate, THIO, in the treatment of advanced non-small cell lung cancer (NSCLC). The Chicago-based biopharmaceutical company is developing THIO as a...
